Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Treasury Shares: 2018-2025

Historic Treasury Shares for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $1.5 million.

  • Verastem's Treasury Shares rose 39.19% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 39.19%. This contributed to the annual value of $1.0 million for FY2024, which is N/A change from last year.
  • Verastem's Treasury Shares amounted to $1.5 million in Q3 2025, which was down 2.87% from $1.5 million recorded in Q2 2025.
  • Over the past 5 years, Verastem's Treasury Shares peaked at $2.9 million during Q2 2021, and registered a low of $142,333 during Q2 2023.
  • Over the past 3 years, Verastem's median Treasury Shares value was $1.1 million (recorded in 2024), while the average stood at $1.1 million.
  • As far as peak fluctuations go, Verastem's Treasury Shares crashed by 94.53% in 2023, and later soared by 671.45% in 2024.
  • Quarterly analysis of 5 years shows Verastem's Treasury Shares stood at $2.8 million in 2021, then crashed by 93.84% to $172,909 in 2022, then slumped by 90.91% to $225,675 in 2023, then surged by 363.21% to $1.0 million in 2024, then soared by 39.19% to $1.5 million in 2025.
  • Its Treasury Shares stands at $1.5 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.8 million for Q1 2025.